| Neo-adjuvant chemotherapy in the treatment of advanced malignant germ cell tumors of ovary S Talukdar, S Kumar, N Bhatla, S Mathur, S Thulkar, L Kumar Gynecologic oncology 132 (1), 28-32, 2014 | 78 | 2014 |
| Multiomic analysis of subtype evolution and heterogeneity in high-grade serous ovarian carcinoma L Geistlinger, S Oh, M Ramos, L Schiffer, RS LaRue, CM Henzler, ... Cancer research 80 (20), 4335-4345, 2020 | 64 | 2020 |
| The prognostic significance of histologic type in early stage cervical cancer–A multi-institutional study I Winer, I Alvarado-Cabrero, O Hassan, QF Ahmed, B Alosh, ... Gynecologic oncology 137 (3), 474-478, 2015 | 64 | 2015 |
| Molecular characterization of endometrial cancer and therapeutic implications Z Chang, S Talukdar, SA Mullany, B Winterhoff Current opinion in obstetrics and gynecology 31 (1), 24-30, 2019 | 46 | 2019 |
| Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: review of surgical technique, complications, and outcome CDS Andikyan V, Khoury-Collado F, Gerst SR, Talukdar S Gynecol Oncol. 2012, 2012 | 23 | 2012 |
| Biological insights into chemotherapy resistance in ovarian cancer MA Glasgow, P Argenta, JE Abrahante, M Shetty, S Talukdar, ... International journal of molecular sciences 20 (9), 2131, 2019 | 22 | 2019 |
| Single-cell sequencing in ovarian cancer: a new frontier in precision medicine B Winterhoff, S Talukdar, Z Chang, J Wang, TK Starr Current Opinion in Obstetrics and Gynecology 31 (1), 49-55, 2019 | 19 | 2019 |
| The impact of a wireless audio system on communication in robotic-assisted laparoscopic surgery: A prospective controlled trial Z Tsafrir, K Janosek-Albright, J Aoun, M Diaz-Insua, AER Abd-El-Barr, ... PLoS One 15 (1), e0220214, 2020 | 13 | 2020 |
| Single-cell RNA sequencing of ovarian cancer: promises and challenges S Talukdar, Z Chang, B Winterhoff, TK Starr Ovarian Cancer: Molecular & Diagnostic Imaging and Treatment Strategies, 113-123, 2021 | 5 | 2021 |
| Symptomatic central hematometra and postablation tubal sterilization syndrome (PATSS) after second generation endometrial ablation S Talukdar, D Eisenstein, R Sangha Journal of Minimally Invasive Gynecology 22 (6), S189, 2015 | 5 | 2015 |
| Defining immune infiltrate heterogeneity by immunophenotyping of tumor micro-environment at single cell level: a step towards more effective personalized immunotherapy in … S Talukdar, E Stock, J Cepela, M Shetty, J Wang, A Nelson, M Macchietto, ... Gynecologic Oncology 162, S52, 2021 | 1 | 2021 |
| Surgery versus primary radiation therapy as initial management in endometrial cancer E Salinas, S Talukdar, V Wagner, S Mott, W Sun, M Goodheart Gynecologic oncology 143 (1), 219, 2016 | 1 | 2016 |
| Who will suffer from postablation pelvic pain? A retrospective analysis of risk factors [7Q] S Talukdar, J Underwood, S Atkinson, R Sangha Obstetrics & Gynecology 127, 141S, 2016 | 1 | 2016 |
| A wireless audio system improves teamwork and communication in robotic laparoscopic surgery Z Tsafrir, K Janosek-Albright, J Aoun, AER Abd-El-Barr, L Schiff, ... Journal of Minimally Invasive Gynecology 22 (6), S8, 2015 | 1 | 2015 |
| Nanoparticle albumin-bound (nab) paclitaxel therapy in patients with primary and recurrent ovarian, fallopian tube, and primary peritoneal carcinoma N Rasool, S Talukdar, Y Wang, RK Hanna, TE Buekers, AR Munkarah, ... Gynecologic Oncology 133, 71, 2014 | 1 | 2014 |
| Comparison of combined positive score, Salgado TIL score, immunofluorescence and single cell RNA sequencing for predicting response to therapy A Johnson, S Chandra, M Shetty, J Cepela, S Talukdar, J Mattson, ... Gynecologic Oncology 162, S117, 2021 | | 2021 |
| Chemotherapy resistance pathways identified by single cell RNA sequencing S Chandra, A Johnson, M Shetty, J Cepela, S Talukdar, J Mattson, ... Gynecologic Oncology 162, S109, 2021 | | 2021 |
| Chemotherapy resistance pathways identified in ovarian cancer patients treated with neoadjuvant chemotherapy using single cell RNA sequencing of matched tumor biopsies TK Starr, S Talukdar, Z Chang, J Cepela, C Tastad, M Shetty, I Schneider, ... Cancer Research 81 (13_Supplement), 1410-1410, 2021 | | 2021 |
| Defining immune infiltrate heterogeneity and its role in ovarian cancer chemotherapy resistance using single cell RNA sequencing. S Talukdar, J Cepela, Z Chang, M Shetty, Y Zhang, M Macchietto, ... CANCER RESEARCH 80 (21), 2020 | | 2020 |
| Abstract PO-013: Defining immune infiltrate heterogeneity and its role in ovarian cancer chemotherapy resistance using single cell RNA sequencing S Talukdar, J Cepela, Z Chang, M Shetty, Y Zhang, M Macchietto, ... Cancer Research 80 (21_Supplement), PO-013-PO-013, 2020 | | 2020 |
